Natalizumab: bound to rebound?
- PMID: 19188569
- DOI: 10.1212/01.wnl.0000341783.33962.5b
Natalizumab: bound to rebound?
Comment on
-
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.Neurology. 2009 Feb 3;72(5):396-401. doi: 10.1212/01.wnl.0000327341.89587.76. Epub 2008 Nov 5. Neurology. 2009. PMID: 18987352 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical